67P High levels of circulating ceramides are associated with poor prognosis in patients with metastatic castration-resistant prostate cancer (mCRPC). - Cattrini, C.; Manfredi, M.; Barboro, P.; Ghirimoldi, M.; Mennitto, A.; Martini, V.; Battioni, A.; Le Van, M.; Biello, F.; Platini, F.; Ruffilli, B.; Branni, C.; et al. (Annals of Oncology, 2022)